JBIO · trading date Oct 14, 2026 · previous close $13.42 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
—
Net income
-$127.41M
Total assets
$349.78M
Total liabilities
$17.26M
Stockholders' equity
$332.52M
Cash & equivalents
$88.44M
Operating income
-$113.54M
Operating cash flow
-$94.69M
Capital expenditures
$196.0K
Fiscal year 2025, via 10-K filed 2026-03-06.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$94.89M
Free cash flow margin
—
Liabilities / assets
4.9%
Equity / assets
95.1%
CapEx / revenue
—
Operating cash flow / net income
0.74×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Waltham, MA 02453
221 CRESCENT ST.
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:35 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.